Loading company…
Next Biomedical develops and sells therapeutic devices and drug delivery systems.
Established in 2014 and based in Incheon, South Korea, Next Biomedical develops and sells therapeutic devices and drug delivery systems. Its products include Nexpowder™ for endoscopic bleeding control and ulcer protection, Nexsphere™ for endovascular embolization, and drug carriers that load registered pharmaceuticals into medical devices.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in